symptoms were highly comparable to what has been reported for a larger cohort (Piskulic et al., 2012), as deterioration in role function was most prominent (with 81% of the current CHR patients reporting a score of 3 or higher), followed by social isolation and withdrawal (71%), avolition (57%), and decreased experience of emotion (48%), with decreased expression of emotion (14%) and decreased ideational richness (14%) being the least frequently reported negative symptoms. The current mean (±SD) total SIPS negative symptom score (12.2 ±6.1) was intermediate between that previously reported for males (13.6 ±7.3) and females (8.9 ±6.6; cf. Piskulic et al., 2012). All CHR patients in the current study met criteria for the attenuated positive symptom syndrome of the SIPS/SOPS.
